Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Cline Christopher R.
CHIEF FINANCIAL OFFICER at Travere Therapeutics. Filing since 24 Jan 2023.
CIK 0001943192
Company
Date
Role
Action
Shares
Amount
Of holding
TVTX
Travere Therapeutics, Inc.
15 Sep 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
50,508
$3.15M
36.6%
TVTX
Travere Therapeutics, Inc.
2 Sep 2026
CHIEF FINANCIAL OFFICER
Sold at will
642
$42.61K
0.5%
TVTX
Travere Therapeutics, Inc.
6 May 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
310
$13.62K
0.3%
TVTX
Travere Therapeutics, Inc.
5 May 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
2,181
$101.74K
1.8%
TVTX
Travere Therapeutics, Inc.
15 Apr 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
1,014
$43.21K
0.9%
TVTX
Travere Therapeutics, Inc.
14 Apr 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
7,248
$303.89K
5.8%
TVTX
Travere Therapeutics, Inc.
13 Apr 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
65
$1.88K
0.1%
TVTX
Travere Therapeutics, Inc.
4 Feb 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
1,745
$56.17K
1.5%
TVTX
Travere Therapeutics, Inc.
3 Feb 2026
CHIEF FINANCIAL OFFICER
Sold at will
7,242
$232.61K
6.0%
TVTX
Travere Therapeutics, Inc.
1 Dec 2025
CHIEF FINANCIAL OFFICER
Sold on a plan
20,000
$700.20K
17.8%
TVTX
Travere Therapeutics, Inc.
4 Sep 2025
CHIEF FINANCIAL OFFICER
Sold on a plan
119
$2.35K
0.1%
TVTX
Travere Therapeutics, Inc.
3 Sep 2025
CHIEF FINANCIAL OFFICER
Sold on a plan
454
$8.26K
0.5%
TVTX
Travere Therapeutics, Inc.
27 Aug 2025
CHIEF FINANCIAL OFFICER
Sold on a plan
470
$8.14K
0.5%
TVTX
Travere Therapeutics, Inc.
5 May 2025
CHIEF FINANCIAL OFFICER
Sold at will
1,784
$37.55K
1.9%
TVTX
Travere Therapeutics, Inc.
11 Apr 2025
CHIEF FINANCIAL OFFICER
Sold at will
48
$630.94
0.1%
TVTX
Travere Therapeutics, Inc.
3 Feb 2025
CHIEF FINANCIAL OFFICER
Sold at will
5,192
$104.46K
5.5%
TVTX
Travere Therapeutics, Inc.
22 Jan 2025
CHIEF FINANCIAL OFFICER
Sold at will
865
$16.38K
1.2%
TVTX
Travere Therapeutics, Inc.
9 Sep 2024
CHIEF FINANCIAL OFFICER
Sold at will
2,490
$28.68K
3.2%
TVTX
Travere Therapeutics, Inc.
4 Sep 2024
CHIEF FINANCIAL OFFICER
Sold at will
514
$4.89K
0.7%
TVTX
Travere Therapeutics, Inc.
11 Apr 2024
CHIEF FINANCIAL OFFICER
Sold at will
54
$363.96
0.1%
TVTX
Travere Therapeutics, Inc.
1 Feb 2024
CHIEF FINANCIAL OFFICER
Sold at will
3,818
$32.57K
5.1%
TVTX
Travere Therapeutics, Inc.
23 Jan 2024
CHIEF FINANCIAL OFFICER
Sold at will
853
$7.74K
1.7%
TVTX
Travere Therapeutics, Inc.
5 Sep 2023
Chief Financial Officer
Sold at will
457
$6.72K
0.9%
TVTX
Travere Therapeutics, Inc.
10 May 2023
Chief Financial Officer
Sold at will
455
$7.55K
0.9%
TVTX
Travere Therapeutics, Inc.
11 Apr 2023
Chief Financial Officer
Sold at will
47
$1.01K
0.1%
TVTX
Travere Therapeutics, Inc.
1 Feb 2023
Chief Financial Officer
Sold, plan not stated
1,588
$34.54K
3.0%
TVTX
Travere Therapeutics, Inc.
24 Jan 2023
Chief Financial Officer
Sold, plan not stated
852
$18.66K
2.5%
27 decisions on file.
